small molecule

CYTOVENE

GANCICLOVIR SODIUM

Loss of exclusivity—loss of exclusivity

CompanyCHEPLAPHARM ARZNEIMITTEL GMBH

Drug detail

Brand name	CYTOVENE
Active ingredient	GANCICLOVIR SODIUM
Strength	EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	INJECTABLE
Route	INJECTION
Modality	Small molecule
FDA approval	June 1989
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.